跳至主要内容
临床试验/NCT03311620
NCT03311620已完成不适用

TH-112: Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate

Fox Chase Cancer Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Compare diagnostic yield

研究概览

简要总结

Needle biopsy samples are routinely collected to evaluate cytomorphology, immunohistochemical markers and for mutational analysis. With regular use of immunotheraputic interventions, needle biospy has become more frequent and requires bigger samples for an increasing battery of tests. There has been no clear consensus on which biopsy needle yields the best biopsy sample. It is unclear if large 19g needle offers better yield than a 22 g needle. Although previous studies comparing 21, 22 and 19g needles have suggested that larger needles yield larger biopsy sizes, conflictng studies have shown that larger biopsies lead to bloodier samples with potentially smaller fragments of tissue, offering no improvement in diagnostic, yield, adequacy or sample size.

This study compares biopsy samples collected using 19g and 22g needles from patients of non small cell lung cancer (NSCLC) scheduled to undergo endobronchial ultrasound (EBUS) and transbroncial needle aspiration (TBNA).

详细描述

Primary Objective To compare the diagnostic yield of 22g and 19g EBUS transbronchial needle aspirate (TBNA)

Secondary Objectives

  1. To compare the sample adequacy of 22g and 19g EBUS TBNA
  2. To compare the sample quality of 22g and 19 g EBUS TBNA

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

The needle size to be used first will be chosen by permuted block randomization scheme by the statistician

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing EBUS TBNA for evaluation of lymphadenopathy, lung nodule or mass
  • Patients must have atypical lymph nodes. Atypical lymph nodes are characterized by >10mm in short axis or lymph nodes 5-10mm in short axis with atypical features.
  • Age > 18 years.
  • Patients must have platelets count > 50,000
  • Ability to understand and willingness to sign a written informed consent and HIPAA consent document
  • WOCBP must agree not to get pregnant until the day of the procedure

排除标准

  • Patients with uncorrectable coagulopathy will be excluded.
  • Patients with hemodynamic instability will be excluded
  • Patients with refractory hypoxemia will be excluded
  • Patients with therapeutic anticoagulant that cannot be held for 2 days before and 1 day after the procedure.
  • Patients who are unable to tolerate general anesthesia according to the anesthesiologist
  • Pregnant or breast feeding.

结局指标

主要结局

Compare diagnostic yield

时间窗: 1 year

Diagnostic yields of 22g and 19g needles will be evaluated by two blinded cytopathologists. Diagnostic yield refers to a specific diagnosis made on the basis of EBUS TBNA samples.

次要结局

  • To compare the sample adequacy of 22g and 19g EBUS TBNA(1 year)
  • To compare the sample quality of 22g and 19 g EBUS TBNA(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Pilot Study to Investigate The Diagnostic Yield and... | 临床试验